Reducing Drop-Out Rates in Long-Term Orphan Drug Trials
Reducing Drop-Out Rates in Long-Term Orphan Drug Trials Strategies to Minimize Drop-Out in Long-Term Rare Disease Clinical Trials Why Long-Term Orphan Drug Trials Face High Drop-Out Rates Orphan drug trials often require extended durations due to the chronic nature of many rare diseases and the limited pool of eligible participants. However, maintaining participant engagement over…
Read More “Reducing Drop-Out Rates in Long-Term Orphan Drug Trials” »
